Strong Hydration Ability of Silk Fibroin Suppresses Formation and Recrystallization of Ice Crystals During Cryopreservation

• Published in: Biomacromolecules Vol. 23; no. 2; pp. 478 - 486
• Main Authors: Fan, Qingrui, Dou, Mengjia, Mao, Junqiang, Hou, Yi, Liu, Shuo, Zhao, Lishan, Lv, Jianyong, Liu, Zhang, Wang, Yilin, Rao, Wei, Jin, Shenglin, Wang, Jianjun
• Format: Journal Article
• Language: English
• Published: United States American Chemical Society 14.02.2022
• Subjects: Cell Survival; Cryopreservation; Cryoprotective Agents - chemistry; Cryoprotective Agents - pharmacology; Fibroins; Humans; Ice
• ISSN: 1525-7797; 1526-4602
• DOI: 10.1021/acs.biomac.1c00700

The cryopreservation (CP) of cell/tissue is indispensable in medical science. However, the formation of ice during cooling and ice recrystallization/growth in time of thawing present significant risk of cell/tissue damage upon analysis of CP process. Herein, the natural and biocompatible silk fibroin (SF) with regular hydrophobic and hydrophilic domains, were first employed as a cryoprotectant (CPA), to the CP of human bone-derived mesenchymal stem cells (hBMSCs), which has been routinely cyropreserved for cell-based therapies. Addtion of SF can regulate the formation of ice crystals during cooling process because of its strong hydration ability in the comparation to the cryopreservation medium (CM) without SF. Moreover, the devitrification-induced recrystallization/growth of ice during the thawing process is suppressed. Most importantly, the addition of 10 mg mL–1 SF can achieve 81.28% cell viability of cryopreserved hBMSCs as similar as those with the addition of 180 mg mL–1 Ficoll 70 (commercial CPA), and the functions of the cryopreserved hBMSCs are maintained as good as that of the fresh ones. This work is not only significant for meeting the ever-increasing demand of cell therapy, but also trailblazing for designing materials in controlling ice formation and growth during the CP of other cells and tissues.